Compare HROW & UTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HROW | UTI |
|---|---|---|
| Founded | 1998 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | N/A | 2003 |
| Metric | HROW | UTI |
|---|---|---|
| Price | $40.06 | $36.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $69.86 | $37.50 |
| AVG Volume (30 Days) | 442.6K | ★ 450.3K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.67 |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $835,616,000.00 |
| Revenue This Year | $31.62 | $10.15 |
| Revenue Next Year | $50.77 | $8.32 |
| P/E Ratio | ★ N/A | $155.39 |
| Revenue Growth | N/A | ★ 14.05 |
| 52 Week Low | $21.18 | $21.29 |
| 52 Week High | $54.98 | $40.41 |
| Indicator | HROW | UTI |
|---|---|---|
| Relative Strength Index (RSI) | 54.95 | 50.25 |
| Support Level | $36.23 | $34.49 |
| Resistance Level | $41.65 | $38.16 |
| Average True Range (ATR) | 1.67 | 1.38 |
| MACD | 0.38 | -0.19 |
| Stochastic Oscillator | 68.77 | 39.29 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
Universal Technical Institute Inc is an educational institution. It provides undergraduate degree, as well as certificate programs for technicians in the automotive, diesel, collision repair, motorcycle and marine fields. The company's reportable segment which includes Universal Technical Institute (UTI) and Concorde Career Colleges, Corporate. Majority of the revenue is generated from UTI segment which provides different kinds of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute, Marine Mechanics Institute and others. It also provides dealer technician training or instructor staffing services to manufacturers.